Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROCHYMAL in Type 1 Diabetes Mellitus
NCT00690066Phase 2Completed
- Sponsor
- Mesoblast Ltd
- Start
- Jun 2008
- Primary completion
- Dec 2010
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of remestemcel-L-rknd in type 1 diabetes mellitus (T1D), sponsored by Mesoblast Ltd. Started Jun 2008; status: completed.
02
Drugs
remestemcel-L-rknd
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00690066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00690066.